24.6 C
New York
Sunday, June 14, 2026

Tag: oral

Southwest Gas Holdings Announces Closing of Secondary Public Offering of Centuri Holdings, Inc. Common Stock

LAS VEGAS, Aug. 11, 2025 /PRNewswire/ -- Southwest Gas Holdings, Inc. (NYSE: SWX) ("Southwest Gas Holdings" or the "Company") today announced the closing of its underwritten...

Ucommune Announces Extraordinary General Meeting

BEIJING, Aug. 11, 2025 /PRNewswire/ -- Ucommune International Ltd (Nasdaq: UK) ("we", "Ucommune" or "the Company") today announced that it will hold the extraordinary...

Top Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Enhances Genioplasty and Corrective Jaw Surgery with Virtual Surgical Planning

Dr. David Salehani, a top Los Angeles oral and maxillofacial surgeon, is revolutionizing chin and jaw surgeries using Virtual Surgical Planning (VSP), a 3D planning...

Vast Secures New Funding and Launches Capital Raise to Accelerate Port Augusta Green Energy Hub

SYDNEY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Vast Renewables (“Vast” or the “Company”), a leading Australian clean energy technology company, today announced that it has secured new funding from existing shareholders and launched a capital raise to support the delivery of its flagship Port Augusta Green Energy Hub and growing international project pipeline. Vast also shared several major milestones for its flagship project, Vast Solar 1 (“VS1”), including environmental approvals and grid connection progress.

Lincoln Educational Services Reports Second Quarter Results and Increases Outlook for Full Year 2025

Conference Call Today at 10:00 a.m. Eastern Daylight Time
Conference Call Today at 10:00 a.m. Eastern Daylight Time

Infosys Transforms ABN AMRO’s Lending Process with nCino Platform Implementation

BENGALURU, India, Aug. 11, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced...

Infosys Transforms ABN AMRO’s Lending Process with nCino Platform Implementation

BENGALURU, India, Aug. 11, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced...

Fusion Fuel Signs Non-Binding Letter of Intent to Enter Joint Venture for Specialized Fuel Project in South Africa

DUBLIN, Ireland, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced the signing of a non-binding Letter of Intent (“LOI”) to form a joint venture (“JV”) with a privately-held South Africa-based specialized fuel company (the “Partner”) aimed at delivering a specialized fuel solution for a project in South Africa. The first project for the JV has been awarded to the Partner by a subsidiary of a multinational food and beverage corporation. The proposed transaction aligns with Fusion Fuel’s strategic focus on near-term, revenue-generating, integrated energy investments.

60 Global Rising Stars from 1,200 Universities will Converge in Singapore for SMU’s 12th Lee Kuan Yew Competition Grand Finals

60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant –

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates

JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOral